IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,418,440 | -23.5% | 141,500 | -30.8% | 0.02% | -24.0% |
| Q2 2023 | $8,386,532 | +144.7% | 204,400 | +113.2% | 0.02% | +127.3% |
| Q1 2023 | $3,426,930 | +602.2% | 95,885 | +627.2% | 0.01% | +450.0% |
| Q2 2022 | $488,000 | -70.3% | 13,185 | -75.6% | 0.00% | -71.4% |
| Q4 2021 | $1,643,000 | -77.7% | 53,981 | -75.4% | 0.01% | -78.1% |
| Q3 2021 | $7,355,000 | -81.1% | 219,300 | -77.6% | 0.03% | -81.7% |
| Q2 2021 | $38,969,000 | +71.3% | 976,900 | +142.8% | 0.18% | +57.7% |
| Q4 2020 | $22,752,000 | +66.2% | 402,400 | +39.5% | 0.11% | +58.6% |
| Q3 2020 | $13,689,000 | +33.0% | 288,492 | +65.2% | 0.07% | +4.5% |
| Q2 2020 | $10,296,000 | +3814.8% | 174,625 | +3033.4% | 0.07% | +3250.0% |
| Q1 2020 | $263,000 | -94.1% | 5,573 | -93.5% | 0.00% | -88.9% |
| Q3 2018 | $4,437,000 | +249.9% | 86,031 | +244.1% | 0.02% | +200.0% |
| Q3 2017 | $1,268,000 | -61.2% | 25,000 | -69.0% | 0.01% | -76.0% |
| Q1 2016 | $3,264,000 | -82.3% | 80,600 | -72.9% | 0.02% | -83.6% |
| Q4 2015 | $18,449,000 | – | 297,900 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |